𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Acarbose controls postprandial hyperproinsulinemia in non-insulin dependent diabetes mellitus

✍ Scribed by Ikuo Inoue; Keiichi Takahashi; Satoru Noji; Takuya Awata; Kiyohiko Negishi; Shigehiro Katayama

Book ID
117371373
Publisher
Elsevier Science
Year
1997
Tongue
English
Weight
236 KB
Volume
36
Category
Article
ISSN
0168-8227

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Postprandial Lipoproteins in Non-insulin
Postprandial Lipoproteins in Non-insulin-dependent Diabetes Mellitus
✍ S.W. Coppack πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 145 KB πŸ‘ 3 views

People with non-insulin-dependent diabetes mellitus (NIDDM) have a higher incidence of cardiovascular disease (CVD) than the non-diabetic population. In addition, NIDDM patients have a spectrum of lipid abnormalities that may confer an increased risk of developing CVD. The pattern of dyslipidaemia s

Case-control study in non-insulin-depend
Case-control study in non-insulin-dependent diabetes mellitus (NIDDM) subjects treated with acarbose
✍ Maria Teresa Guagnano; Fulvio Della Loggia; Valeria Pace-Palitti; Rosa Spoltore; πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 95 KB πŸ‘ 2 views

Newer therapeutic approaches are being employed for the treatment of diabetes mellitus, and among these, acarbose, an Ξ±-glucosidase inhibitor, has proven effective in lowering postprandial blood glucose levels and glycosylated hemoglobin. The aim of the present study was to evaluate the effects of